Cargando…
The MARVEL trial: a phase 2b randomised placebo-controlled trial of oral MitoQ in moderate ulcerative colitis
Ulcerative colitis (UC) is an inflammatory disease of the large bowel which is characterised by dysregulated immunity and death to epithelial cells in the bowel, leading to prolonged inflammation. This can ultimately lead to surgery to remove the large bowel, with a risk of cancer developing if infl...
Autores principales: | Gwyer Findlay, Emily, Sutton, Greg, Ho, Gwo-Tzer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585668/ https://www.ncbi.nlm.nih.gov/pubmed/36284899 http://dx.doi.org/10.1093/immadv/ltaa002 |
Ejemplares similares
-
An overview of CAR T-cell clinical trial activity to 2021
por: Adami, Antonella, et al.
Publicado: (2021) -
Peanut oral immunotherapy: current trends in clinical trials
por: Reinwald, Simone, et al.
Publicado: (2022) -
Beyond Ipilimumab: a review of immunotherapeutic approaches in clinical trials in melanoma
por: Middleton, Gary
Publicado: (2020) -
A summary of current NKG2D-based CAR clinical trials
por: Curio, Sophie, et al.
Publicado: (2021) -
A glutamine ‘tug-of-war’: targets to manipulate glutamine metabolism for cancer immunotherapy
por: Pallett, Laura J, et al.
Publicado: (2021)